All Mallinckrodt Pharmaceuticals articles

  • Pharmaceuticals

    DOJ intervenes in whistleblower suit against Mallinckrodt


    The Department of Justice has intervened in a whistleblower lawsuit against Mallinckrodt over allegations the drug maker knowingly underpaid Medicaid rebates it owed due to significant price increases to its drug Acthar.

  • oxy_450x200_-_homepage

    The compliance side of the war on drugs


    In a precedent-setting case, drugmaker Mallinckrodt Pharmaceuticals has agreed to a $35 million settlement with the U.S. federal government for failing to monitor its sales channels for suspicious orders.